Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Drug Discovery Today: Disease Mechanisms, 1(7), p. e43-e59, 2010

DOI: 10.1016/j.ddmec.2010.09.004

Links

Tools

Export citation

Search in Google Scholar

Does M. tuberculosis genomic diversity explain disease diversity?

Journal article published in 2010 by Mireilla Coscolla ORCID, Sebastien Gagneux
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The outcome of tuberculosis infection and disease is highly variable. This variation has been attributed primarily to host and environmental factors, but better understanding of the global genomic diversity in the M. tuberculosis complex (MTBC) suggests that bacterial factors could also be involved. Review of nearly 100 published reports shows that MTBC strains differ in their virulence and immunogenicity in experimental models, but whether this phenotypic variation plays a role in human disease remains unclear. Given the complex interactions between the host, the pathogen and the environment, linking MTBC genotypic diversity to experimental and clinical phenotypes requires an integrated systems epidemiology approach embedded in a robust evolutionary framework.